PMDA drug package insert
ガノン顆粒KA-II
PMDA OTC drug · 天野商事（株） · package insert Jun 23, 2023
Key facts
| Brand names | ガノン顆粒KA-II |
|---|---|
| Companies | 製造販売元／アスゲン製薬（株）,販売会社／天野商事（株） |
| Product type | OTC drug |
| OTC risk class | 第「２」類医薬品 |
| OTC dosage form | 散剤 |
| OTC effect category | かぜ薬（内用） |
| Package insert date | Jun 23, 2023 |
| PMDA document key | 100122_J1301000205 |
| PMDA company code | 100122 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- 1–9 Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: